Editorial: Immune-mediated Lung Injury

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Nov 29

PMID 38020172

Authors

Theodoros Karampitsakos

Paolo Spagnolo

Argyris Tzouvelekis

Affiliations

Soon will be listed here.

References

Kumar V . Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury. Front Immunol. 2020; 11:1722. PMC: 7417316. DOI: 10.3389/fimmu.2020.01722. View

Alahdal M, Elkord E . Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities. Clin Immunol. 2022; 245:109177. PMC: 9640209. DOI: 10.1016/j.clim.2022.109177. View

Karampitsakos T, Papaioannou O, Tsiri P, Katsaras M, Katsimpris A, Kalogeropoulos A . Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial. Clin Microbiol Infect. 2022; 29(3):372-378. PMC: 9636985. DOI: 10.1016/j.cmi.2022.10.015. View

Crystal R, Fulmer J, Roberts W, Moss M, Line B, Reynolds H . Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med. 1976; 85(6):769-88. DOI: 10.7326/0003-4819-85-6-769. View

Kreuter M, Lee J, Tzouvelekis A, Oldham J, Molyneaux P, Weycker D . Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021; 204(1):74-81. PMC: 8437112. DOI: 10.1164/rccm.202003-0669OC. View

Kusnadi A, Ramirez-Suastegui C, Fajardo V, Chee S, Meckiff B, Simon H . Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8 T cells. Sci Immunol. 2021; 6(55). PMC: 8101257. DOI: 10.1126/sciimmunol.abe4782. View

Melms J, Biermann J, Huang H, Wang Y, Nair A, Tagore S . A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021; 595(7865):114-119. PMC: 8814825. DOI: 10.1038/s41586-021-03569-1. View

Mehta P, Sanz-Magallon Duque de Estrada B, Denneny E, Foster K, Turner C, Mayer A . Single-cell analysis of bronchoalveolar cells in inflammatory and fibrotic post-COVID lung disease. Front Immunol. 2024; 15:1372658. PMC: 11140060. DOI: 10.3389/fimmu.2024.1372658. View

Scott M, Quinn K, Li Q, Carroll R, Warsinske H, Vallania F . Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. Lancet Respir Med. 2019; 7(6):497-508. PMC: 6529612. DOI: 10.1016/S2213-2600(18)30508-3. View

10.

Davis H, McCorkell L, Vogel J, Topol E . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023; 21(3):133-146. PMC: 9839201. DOI: 10.1038/s41579-022-00846-2. View

11.

Karampitsakos T, Juan-Guardela B, Tzouvelekis A, Herazo-Maya J . Precision medicine advances in idiopathic pulmonary fibrosis. EBioMedicine. 2023; 95:104766. PMC: 10469771. DOI: 10.1016/j.ebiom.2023.104766. View

12.

Desai S, Hansell D, Walker A, MacDonald S, Chabat F, Wells A . Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent. Eur Radiol. 2006; 17(4):911-8. DOI: 10.1007/s00330-006-0369-0. View

13.

Schulte-Schrepping J, Reusch N, Paclik D, Bassler K, Schlickeiser S, Zhang B . Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020; 182(6):1419-1440.e23. PMC: 7405822. DOI: 10.1016/j.cell.2020.08.001. View

14.

Raghu G, Anstrom K, King Jr T, Lasky J, Martinez F . Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012; 366(21):1968-77. PMC: 3422642. DOI: 10.1056/NEJMoa1113354. View

15.

Karampitsakos T, Torrisi S, Antoniou K, Manali E, Korbila I, Papaioannou O . Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis. Respir Res. 2021; 22(1):140. PMC: 8097815. DOI: 10.1186/s12931-021-01725-9. View

16.

Herazo-Maya J, Sun J, Molyneaux P, Li Q, Villalba J, Tzouvelekis A . Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med. 2017; 5(11):857-868. PMC: 5677538. DOI: 10.1016/S2213-2600(17)30349-1. View

17.

Juan Guardela B, Sun J, Zhang T, Xu B, Balnis J, Huang Y . 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study. EBioMedicine. 2021; 69:103439. PMC: 8214725. DOI: 10.1016/j.ebiom.2021.103439. View